Water, Sanitation, and Hygiene Mobile Health Messages as an Innovative Tool to Facilitate Behavior Change

Learn more about:
Related Clinical Trial
A Phase III Randomized, Modified Double-blind, Multi-centric, Comparative Study, to Evaluate the Non-inferiority of Immunogenicity and Safety of Hillchol® (BBV131)to Shanchol™ Along With Lot-to-lot Consistency of Hillchol®(BBV131). Immune Response to a Delayed Second Dose of Oral Cholera Vaccine Preventative Intervention for Cholera for 7 Days Impact Study of Cholera Vaccination in Endemic Areas – Clinical Surveillance Water, Sanitation, and Hygiene Mobile Health Messages as an Innovative Tool to Facilitate Behavior Change Non-Inferiority, Safety and Lot-to-Lot Consistency of Oral Cholera Vaccine-Simplified Compared to Shanchol™ in Nepalese Safety and Immunogenicity of Peru-15 Vaccine When Given With Measles Vaccine in Healthy Indian and Bangladeshi Infants Safety and Immunogenicity of Single Dose Choleragarde® in HIV-Seropositive Adults PXVX0200 (CVD103-HgR) vs Shanchol in Mali Cholera-Hospital-Based-Intervention-for-7-days A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults A Phase 3 Lot to Lot Consistency Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Adults Follow-up of Pregnant Women After a Mass Vaccination of Oral Cholera Vaccine (ShancholTM) in Nsanje Malawi Single Dose Azithromycin in the Treatment of Adult Cholera Safety and Immunogenicity of a New Formulation of Euvichol® Cholera Anti-Secretory Treatment Trial PK Study of iOWH032 in Adult Male/Female Healthy Volunteers & Adult Males With Cholera Single Dose Ciprofloxacin in the Treatment of Childhood Cholera:Randomized Controlled Clinical Trial Efficacy of Benefiber-Added, Reduced-Osmolarity WHO-ORS in the Treatment of Cholera in Adults Safety and Immunogenicity of Locally Manufactured New (HL-OCV) Oral Cholera Vaccine Zinc Supplementation in Cholera Patients Immunologic Responses to a Live Attenuated Oral Cholera Vaccine Pilot Introduction of Oral Cholera Vaccine in Orissa, India Safety and Immunogenicity of the Live Oral Cholera Vaccine Candidate PXVX0200 Immunity to Human Cholera in Bangladesh Ciprofloxacin Multiple Dose for Adult Cholera Effect of Probiotic on Immunogenicity of Oral Cholera Vaccine Effectiveness of a Bivalent Killed Whole Cell Based Oral Cholera Vaccine Safety and Efficacy Challenge Study of Live Oral Cholera Vaccine Candidate,PXVX0200, to Prevent Cholera Impact Evaluation of Urban Water Supply Improvements on Cholera and Other Diarrhoeal Diseases in Uvira, Democratic Republic of Congo Protective Immunity to Human Cholera in Bangladesh Safety and Immunogenicity of a New Formulation of a Bivalent Killed, Whole-Cell Oral Cholera Vaccine Oral Cholera Vaccine Delivery in Rural Bangladesh Study of Alternative Vaccination Schedule of Oral Cholera Vaccine Mass Oral Cholera Vaccination in Zanzibar Cholera Vaccine Investment Strategy in Bangladesh Immunogenicity of One Versus Two Doses of Killed Oral Cholera Vaccine Bridging Study for Killed Oral Cholera Vaccine in Ethiopia Safety and Immunogenicity of Locally Manufactured Oral Cholera Vaccine Effect of Extended Dose Intervals on the Immune Response to Oral Cholera Vaccine A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in Dominican Republic Introduction of Cholera Vaccine in Bangladesh Evaluation of a Pilot Program to Introduce Cholera Vaccine in Haiti as Part of Global Cholera Control Efforts Single Dose Oral Cholera Vaccine Study in Dhaka, Bangladesh Evaluation of a Boosting Regimen With Oral Cholera Vaccine Single Dose Azithromycin to Prevent Cholera in Children Safety and Immunogenicity of Oral Cholera Vaccine in Kolkata A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in the Philippines Randomized Controlled Trial of Killed Oral Cholera Vaccine in Kolkata

Brief Title

Water, Sanitation, and Hygiene Mobile Health Messages as an Innovative Tool to Facilitate Behavior Change

Official Title

Water, Sanitation, and Hygiene Mobile Health Messages as an Innovative Tool to Facilitate Behavior Change (CHoBI7 Program)

Brief Summary

      Develop a scalable approach for delivering water, sanitation, and hygiene (WASH) messages to
      households in areas with confirmed cholera patients in Dhaka, Bangladesh. This will be done
      by conducting formative research through in-depth interviews, focus group discussions, and
      intervention planning workshops with households in areas with confirmed cholera patients and
      government officials to identify perceptions of WASH behaviors and to inform the development
      of a mobile health intervention (mHealth) for this population. This intervention approach
      will then be piloted in a subset of households, and revised according to feedback. Then the
      investigators will conduct a randomized controlled of the refined mHealth intervention.
    

Detailed Description

      Aim 1. Develop an evidence and theory based WASH mHealth intervention for households in areas
      with confirmed cholera patients in Dhaka, Bangladesh through formative research

        1. Conduct formative research through in-depth interviews, focus group discussions, and
           intervention planning workshops with caregivers and household members of young children,
           and government officials to identify perceptions of WASH behaviors and to inform the
           development of intervention materials.

        2. Pilot the WASH mHealth intervention in a subset of households, and revise according to
           feedback.

      Aim 2: Evaluate the effectiveness of the developed WASH mHealth intervention in increasing
      WASH behaviors and reducing fecal contamination on hands and in stored drinking water by
      conducting a RCT

        1. Recruit and prospectively follow for 12 months 120 households (600 participants, 4 per
           household) with a child under five years of age assigned to one of two study arms (60
           households per arm). The first arm will receive the CHoBI7 mHealth program (CHoBI7
           mHealth program Arm) and the second arm will serve as a Control Arm and only receive a
           general message on oral rehydration solution (ORS).

        2. Compare the 2 study arms using structured observation of handwashing with soap at stool
           and food related events, unannounced spot checks of the presence of soap in the cooking
           and latrine areas of the household, and fecal coliform counts on caregiver hands and in
           stored drinking water.
    


Study Type

Interventional


Primary Outcome

Handwashing with soap at stool and food related events

Secondary Outcome

 Incidence of Diarrhea

Condition

Cholera

Intervention

CHoBI7 mHealth program Arm

Study Arms / Comparison Groups

 CHoBI7 mHealth program Arm
Description:  The first arm will receive the CHoBI7 mHealth program and a general message on oral rehydration solution (ORS) (CHoBI7 mHealth program Arm) .

Publications

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information


Recruitment Status

Behavioral

Estimated Enrollment

284

Start Date

March 22, 2021

Completion Date

November 28, 2021

Primary Completion Date

November 28, 2021

Eligibility Criteria

        Inclusion Criteria:

          -  At least one household member must report ownership of an active mobile phone in their
             possession on the day of enrollment

        Exclusion Criteria:

          -  Household has a tap or basin with running water inside their home.
      

Gender

All

Ages

N/A - N/A

Accepts Healthy Volunteers

Accepts Healthy Volunteers

Contacts

Christine Marie George, PhD, , 

Location Countries

Bangladesh

Location Countries

Bangladesh

Administrative Informations


NCT ID

NCT04816552

Organization ID

9255


Responsible Party

Sponsor

Study Sponsor

Johns Hopkins Bloomberg School of Public Health


Study Sponsor

Christine Marie George, PhD, Principal Investigator, Johns Hopkins Bloomberg School of Public Health


Verification Date

August 2022